Published Date: 11/29/2021
This is a Tailored case study for clinicians who care for patients with chronic pain and opioid use disorder.
Since this training was published, the federal requirement for practitioners to have a waiver (commonly referred to as the X-Waiver) to prescribe buprenorphine was removed. Additionally, practitioners no longer need to file a notice of intent (NOI) and the limit on the number of patients a practitioner can treat with buprenorphine has been removed. Learn more about these federal changes here.
Laila Khalid, MD is an Associate Professor of Medicine at Albert Einstein College of Medicine/Montefiore Medical Center. She is board-certified in internal and addiction medicine. She codirects a resident-led chronic pain clinic and is an eConsultant for opioid management of ambulatory patients at Montefiore. She is also a buprenorphine clinic site champion and leads the Buprenorphine Microdosing Working Group at Montefiore.
